Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines

Bibliographic Details
Main Authors:	Nicolas Çuburu, Olivera J. Finn, Sjoerd H. Van Der Burg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Immunology
Subjects:	vaccine immunotherapy antigen discovery animal model premalignant lesion tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.924099/full

Similar Items

Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis
by: M. Rita I. Young, et al.
Published: (2015-06-01)

Trace elements as a diagnostic biomarker for premalignant lesions and malignant conditions
by: Surekha Rathod, et al.
Published: (2019-01-01)

Fabrication of astaxanthin-loaded electrospun nanofiber-based mucoadhesive patches with water‐insoluble backing for the treatment of oral premalignant lesions
by: Hui Zhang, et al.
Published: (2022-11-01)

Treatment Results of Vulvar Intraepithelial Neoplasia in 16 Women
by: Cüneyt Eftal Taner, et al.
Published: (2008-12-01)

Role of Vitamin E in Prevention of Oral Cancer:-A Review
by: Md. Asad Iqubal, et al.
Published: (2014-10-01)

Epidemiology, Risk Factors for Gastric Cancer and Surveillance of Premalignant Gastric Lesions: A Prospective Cohort Study of Central Saudi Arabia
by: Georgios Zacharakis, et al.
Published: (2023-09-01)

Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression
by: Boting Ning, et al.
Published: (2023-05-01)

Investigation of early neoplastic transformation and premalignant biology using genetically engineered organoid models
by: Hua Zhao, et al.
Published: (2022-01-01)

Epigenetic reprogramming in pancreatic premalignancy and clinical implications
by: Wei Zhang, et al.
Published: (2023-02-01)

Comparative Analysis between Reid’s Colposcopic Index and Swede’s Score for Detection of Premalignant Lesions of Cervix: A Prospective Study
by: Smriti Pandey, et al.
Published: (2023-04-01)

Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology
by: Pavol Zubor, et al.
Published: (2020-10-01)

Epidemiology of oral cancers and the importance of their early detection. Oral screening 2018
by: Lajos Döbrőssy, et al.
Published: (2018-03-01)

Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
by: Vlad Denis Constantin, et al.
Published: (2023-10-01)

Expression of ICAM-1 in Blood Vascular Endothelium and Tissues in Human Premalignant Lesion and Gastric/Hepatocellular Carcinomas
by: Li Kang, et al.
Published: (2022-04-01)

Histopathological Outcome of Oral Lesions in Pakistani Population with Special Emphasis on Oral Cancer
by: Amna Waheed, et al.
Published: (2022-09-01)

Role of immunomarkers (P16 and Ki67) in identifying pre-malignant and malignant lesion of cervix: a comparative study
by: Tradeep Saluja, et al.
Published: (2023-08-01)

Antioxidants: Are we abusing it?
by: T G Shrihari, et al.
Published: (2012-01-01)

Evaluation of Salivary Lactate Dehydrogenase Level as a Biomarker for Early Detection in Oral Cancer and Potentially Malignant Disorders: A Systematic Review and Meta-analysis
by: Arunima Sarma, et al.
Published: (2023-07-01)

Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract
by: Axel Lechner, et al.
Published: (2024-04-01)

The impact of the COVID‐19 pandemic on the diagnosis and treatment of skin cancers, a mini review
by: Zeinab Aryanian, et al.
Published: (2023-09-01)

New opportunities for nanoparticles in cancer immunotherapy
by: Wooram Park, et al.
Published: (2018-09-01)

Evaluation Criteria for Chromosome Instability Detection by FISH to Predict Malignant Progression in Premalignant Glottic Laryngeal Lesions
by: Verona E. Bergshoeff, et al.
Published: (2022-07-01)

Immunohistochemical Expression of E-cadherin in Premalignant and Malignant Squamous Lesions of the Oral Cavity: A Cross-sectional Study
by: Basavaraj Yamakanamardi, et al.
Published: (2023-10-01)

Awareness and knowledge of tobacco associated risk of development of oral cancer and oral potentially malignant disorders among patients visiting a dental college
by: Vidya Kadashetti, et al.
Published: (2020-01-01)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
by: Kechao Nie, et al.
Published: (2022-05-01)

MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma
by: Elena Fernandez-Castañer, et al.
Published: (2021-05-01)

Evaluation of Hearing Impairment and Levels of Trace Elements in Patients with Oral Submucous Fibrosis
by: Surekha Rathod, et al.
Published: (2023-01-01)

The Extracellular Metabolome Stratifies Low and High Risk Potentially Premalignant Oral Keratinocytes and Identifies Citrate as a Potential Non-Invasive Marker of Tumour Progression
by: Lee Peng Karen-Ng, et al.
Published: (2021-08-01)

The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy
by: Yae Kye, et al.
Published: (2022-08-01)

New insights into the role of the oral leukoplakia microenvironment in malignant transformation
by: Wilfredo Alejandro González-Arriagada, et al.
Published: (2024-02-01)

Comparative Study of Cervical Pap Smear and Visual Inspection of The Cervix To Detect Premalignant Disease of The Cervix
by: Rozhan Yassin Khalil, et al.
Published: (2020-06-01)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
by: Yiwen Zheng, et al.
Published: (2023-06-01)

Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
by: Emilio Garcia-Mouronte, et al.
Published: (2023-06-01)

Inflammatory microenvironment in gastric premalignant lesions: implication and application
by: Shengxiong Zhang, et al.
Published: (2023-11-01)

An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
by: Ke-wei Wang, et al.
Published: (2022-10-01)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
by: Wei Zhang, et al.
Published: (2023-04-01)

Predictors of anemia without active bleeding signs in patients referred for endoscopy
by: Munteanu Sabrina Nicoleta, et al.
Published: (2023-09-01)

Risk factors in the development of gastric adenocarcinoma in the general population: A cross-sectional study of the Wuwei Cohort
by: Zhaofeng Chen, et al.
Published: (2023-01-01)

Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
by: Zhicheng Jin, et al.
Published: (2022-10-01)

Future Challenges in Cancer Resistance to Immunotherapy
by: Marit J. van Elsas, et al.
Published: (2020-04-01)